← Back to Search

Estrogen

Revaree for Genitourinary Syndrome

N/A
Waitlist Available
Led By Lila Nachtigall, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 12
Awards & highlights

Study Summary

This trial is studying whether a hyaluronic acid vaginal insert is as effective as vaginal estrogen in treating symptoms of genitourinary syndrome of menopause.

Eligible Conditions
  • Genitourinary Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in VSQ Score
Secondary outcome measures
Change in VAS Score - Dyspareunia
Change in VMI
Change in Vaginal pH

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InvestigationalExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Revaree
2021
N/A
~50

Find a Location

Who is running the clinical trial?

JDS Therapeutics, LLCIndustry Sponsor
NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,672 Total Patients Enrolled
Lila Nachtigall, MDPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
44 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause
2021. "A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04544475.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top